Skip to content

13F-HR filed by Stonepine Capital Management, LLC

Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-13, with 58 holding rows worth $123,007,632.

Accession
0000935836-25-000666
Filed
2025-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 58 entries on the cover page, a total value of $123,007,632 stated on the cover page (in dollars after the unit check, H1), rows summing to $123,007,632 with VALUE read as dollars as filed, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VERASTEM INC92337C203COMMON STOCK2,670,032$23,576,383dollars as filed
ADMA BIOLOGICS INC000899104COM739,000$10,833,740dollars as filed
EVOLUS INC30052C107COM1,536,391$9,433,441dollars as filed
ZEVRA THERAPEUTICS INC COM NEW488445206Stock810,000$7,703,100dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK85,000$4,836,500dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock647,382$4,564,043dollars as filed
XOMA ROYALTY CORPORATION98419J206COMMON STOCK115,459$4,449,790dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM174,544$3,724,769dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM305,000$3,650,850dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK1,056,338$3,612,676dollars as filed
OMNIAB INC68218J103COM2,142,857$3,428,571dollars as filed
SURROZEN INC86889P208COMMON STOCK250,146$3,223,131dollars as filed
TELA BIO INC872381108COM2,155,519$3,211,723dollars as filed
Indivior PLCG4766E116Common Stock100,000$2,411,000dollars as filed
ABEONA THERAPEUTICS INC00289Y206COM NEW450,970$2,381,122dollars as filed
GERON CORP374163103COM1,600,000$2,192,000dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM1,370,139$1,918,195dollars as filed
EDESA BIOTECH INC27966L306COM NEW687,500$1,698,125dollars as filed
AYTU BIOPHARMA INC054754858COM891,855$1,676,687dollars as filed
SOLENO THERAPEUTICS INC834203309COM24,000$1,622,400dollars as filed
KEZAR LIFE SCIENCES INC49372L209COM NEW383,182$1,494,410dollars as filed
ALUMIS INC022307102COM300,000$1,197,000dollars as filed
INHIBIKASE THERAPEUTICS INC45719W205COMMON STOCK735,019$1,190,731dollars as filed
BIOAGE LABS INC COM09077V100Stock188,571$1,108,797dollars as filed
ARDELYX INC039697107COM200,000$1,102,000dollars as filed
PULMONX CORP745848101COM670,000$1,085,400dollars as filed
DYNAVAX TECHNOLOGIES CORP268158201COM NEW108,094$1,073,373dollars as filed
HERON THERAPEUTICS INC427746102COM850,100$1,071,126dollars as filed
VANDA PHARMACEUTICALS INC921659108COM195,000$973,050dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM160,000$913,600dollars as filed
MANNKIND CORP COM NEW56400P706Stock157,569$846,146dollars as filed
MAXCYTE INC57777K106COM459,018$725,248dollars as filed
AN2 THERAPEUTICS INC037326105COM563,913$716,170dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK453,800$685,238dollars as filed
ANGIODYNAMICS INC03475V101COM60,000$670,200dollars as filed
GRACE THERAPEUTICS INC00439U104COM211,010$628,177dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM20,000$601,600dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM37,200$572,322dollars as filed
AQUESTIVE THERAPEUTICS INC COM03843E104Stock100,600$562,354dollars as filed
GOSSAMER BIO INC COM38341P102Stock204,770$538,545dollars as filed
BOUNDLESS BIO INC10170A100COM413,453$508,547dollars as filed
HEALTH CATALYST INC42225T107COM155,551$443,320dollars as filed
ESTABLISHMENT LABS HOLDINGSG31249108COMMON STOCK10,585$433,879dollars as filed
PLIANT THERAPEUTICS INC729139105COM289,237$428,071dollars as filed
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK125,000$398,750dollars as filed
KIORA PHARMACEUTICALS INC49721T507COM140,598$390,862dollars as filed
REZOLUTE INC76200L309COMMON STOCK40,000$376,000dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock192,900$366,510dollars as filed
IN8BIO INC45674E208COM NEW159,421$345,944dollars as filed
SOLANA CO42328V876COM CL A NEW20,000$297,800dollars as filed
CODEXIS INC192005106COM88,264$215,364dollars as filed
SAVARA INC805111101COM60,000$214,200dollars as filed
ABIVAX SA-00370M103SPONSORED ADS2,500$212,250dollars as filed
PROCESSA PHARMACEUTICALS INC74275C304COM SHS1,030,200$197,695dollars as filed
LARIMAR THERAPEUTICS INC517125100COM25,000$80,750dollars as filed
CHEMOMAB THERAPEUTICS LTD16385C203SPONSORED ADS30,000$78,900dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN35,253$66,981dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW20,200$48,076dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000935836-25-000666this filing2025-11-13acceptance time not in the bulk data set